Cystadenocarcinoma, Serous

Displaying 1 - 3 of 3CSV
Lee, M. W., Anderson, Z. S., Girma, A. M., Klar, M., Roman, L. D., Carlson, J. W., Wright, J. D., Sood, A. K., & Matsuo, K. (2024). Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma. Obstetrics & Gynecology, 143(5), 660–669. https://doi.org/10.1097/aog.0000000000005562
Publication Date
Matsuo, K., Matsuzaki, S., Maeda, M., Rau, A. R., Yoshihara, K., Tamura, R., Shimada, M., Machida, H., Mikami, M., Klar, M., Roman, L. D., Wright, J. D., Sood, A. K., & Gershenson, D. M. (2023). Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas. JAMA Network Open, 6(6), e2318602. https://doi.org/10.1001/jamanetworkopen.2023.18602
Publication Date
Yoshioka, T., Suzuki, Y., Imai, Y., Ruiz‐Yokota, N., Yamanaka, S., Furuya, M., & Miyagi, E. (2021). Inspection for micrometastasis is essential for predicting the prognosis of serous endometrial intraepithelial carcinoma: Case report and literature review. Journal of Obstetrics and Gynaecology Research, 47(12), 4484–4489. Portico. https://doi.org/10.1111/jog.15020
Publication Date